Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-12

Clinical Trial Update: Study of Efficacy of Ramelteon in Adults With Chronic Insomnia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ramelteon in adults with chronic insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROZEREM (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Chronic Insomnia | Phase 3 | Status: COMPLETED